CytoSorbents Reports Third Quarter 2023 Financial and Operat

Q3 2023 Product sales grew 20% to $7.8M versus $6.5M in Q3 2022. Q3 2023 Total revenue was approximately $8.8M. The pivotal STAR-T trial remains blinded with database lock nearing and initial data analysis completion expected before year-end.PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorptio

Related Keywords

Canada , State Of New Jersey , New Jersey , United States , Germany , New York , American , Canadian , Kathleen Bloch , Vincent Capponi , James Komsa , Phillip Chan , Irina Kulinets , Efthymios Deliargyris , Health Canada , National Heart , Bus Company Contact , Fresenius , Development Expenses , Us Centers Of Medicare Medicaid Services , National Institutes Of Health , Human Services , Cytosorbents Corporation , Blood Institute , Facebook , Pfizer , Material Command , Us Department Of Health , European Union , Us Army , Us Air , Medtronic , Vascular Group , Fresenius Medical Care , Company Board Of Directors , Astrazeneca , Sorbents Corporation , Operating Highlights , Chief Executive Officer , Timely Antithrombotic Removal , Safety Monitoring Board , Global Regulatory , Device Designation , American Journal , Cardiovascular Drugs , Quality Star Rating , Medicaid Services , Chief Operating Officer , Chief Medical Officer , Vice President , Northeast Cardiac , Critical Care , Blood Purification , Medical Care , Acute Therapies , Renal Therapies , Administrative Expenses , Foreign Currency Transactions , Capital Resources , Call Details , Presentation Webcast , Investor Relations , Use Authorization , Device Designations , Timely Antithrombotic Removal Ticagrelor , National Institutes , Operations Command , Air Force Material Command , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Cardiac Surgery , Cardiothoracic Surgery , Product Sales , Total Revenue ,